Loading…

Development of a 3Mut-Apex-Stabilized Envelope Trimer That Expands HIV-1 Neutralization Breadth When Used To Boost Fusion Peptide-Directed Vaccine-Elicited Responses

HIV-1 envelope (Env) trimers, stabilized in a prefusion-closed conformation, can elicit humoral responses capable of neutralizing HIV-1 strains closely matched in sequence to the immunizing strain. One strategy to increase elicited neutralization breadth involves vaccine priming of immune responses...

Full description

Saved in:
Bibliographic Details
Published in:Journal of virology 2020-06, Vol.94 (13)
Main Authors: Chuang, Gwo-Yu, Lai, Yen-Ting, Boyington, Jeffrey C, Cheng, Cheng, Geng, Hui, Narpala, Sandeep, Rawi, Reda, Schmidt, Stephen D, Tsybovsky, Yaroslav, Verardi, Raffaello, Xu, Kai, Yang, Yongping, Zhang, Baoshan, Chambers, Michael, Changela, Anita, Corrigan, Angela R, Kong, Rui, Olia, Adam S, Ou, Li, Sarfo, Edward K, Wang, Shuishu, Wu, Winston, Doria-Rose, Nicole A, McDermott, Adrian B, Mascola, John R, Kwong, Peter D
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c411t-9eb505d93198be1fe106026eb9cae8213290b1fc90a4badeb7d772df33f436703
cites cdi_FETCH-LOGICAL-c411t-9eb505d93198be1fe106026eb9cae8213290b1fc90a4badeb7d772df33f436703
container_end_page
container_issue 13
container_start_page
container_title Journal of virology
container_volume 94
creator Chuang, Gwo-Yu
Lai, Yen-Ting
Boyington, Jeffrey C
Cheng, Cheng
Geng, Hui
Narpala, Sandeep
Rawi, Reda
Schmidt, Stephen D
Tsybovsky, Yaroslav
Verardi, Raffaello
Xu, Kai
Yang, Yongping
Zhang, Baoshan
Chambers, Michael
Changela, Anita
Corrigan, Angela R
Kong, Rui
Olia, Adam S
Ou, Li
Sarfo, Edward K
Wang, Shuishu
Wu, Winston
Doria-Rose, Nicole A
McDermott, Adrian B
Mascola, John R
Kwong, Peter D
description HIV-1 envelope (Env) trimers, stabilized in a prefusion-closed conformation, can elicit humoral responses capable of neutralizing HIV-1 strains closely matched in sequence to the immunizing strain. One strategy to increase elicited neutralization breadth involves vaccine priming of immune responses against a target site of vulnerability, followed by vaccine boosting of these responses with prefusion-closed Env trimers. This strategy has succeeded at the fusion peptide (FP) site of vulnerability in eliciting cross-clade neutralizing responses in standard vaccine-test animals. However, the breadth and potency of the elicited responses have been less than optimal. Here, we identify three mutations (3mut), Met302, Leu320, and Pro329, that stabilize the apex of the Env trimer in a prefusion-closed conformation and show antigenically, structurally, and immunogenically that combining 3mut with other approaches (e.g., repair and stabilize and glycine-helix breaking) yields well-behaved clade C-Env trimers capable of boosting the breadth of FP-directed responses. Crystal structures of these trimers confirmed prefusion-closed apexes stabilized by hydrophobic patches contributed by Met302 and Leu320, with Pro329 assuming canonically restricted dihedral angles. We substituted the N-terminal eight residues of FP (FP8, residues 512 to 519) of these trimers with the second most prevalent FP8 sequence (FP8v2, AVGLGAVF) and observed a 3mut-stabilized consensus clade C-Env trimer with FP8v2 to boost the breadth elicited in guinea pigs of FP-directed responses induced by immunogens containing the most prevalent FP8 sequence (FP8v1, AVGIGAVF). Overall, 3mut can stabilize the Env trimer apex, and the resultant apex-stabilized Env trimers can be used to expand the neutralization breadth elicited against the FP site of vulnerability. A major hurdle to the development of an effective HIV-1 vaccine is the elicitation of serum responses capable of neutralizing circulating strains of HIV, which are extraordinarily diverse in sequence and often highly neutralization resistant. Recently, we showed how sera with 20 to 30% neutralization breadth could, nevertheless, be elicited in standard vaccine test animals by priming with the most prevalent N-terminal 8 residues of the HIV-1 fusion peptide (FP8), followed by boosting with a stabilized BG505-envelope (Env) trimer. Here, we show that subsequent boosting with a 3mut-apex-stabilized consensus C-Env trimer, modified to have the second mo
doi_str_mv 10.1128/JVI.00074-20
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7307166</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2390647021</sourcerecordid><originalsourceid>FETCH-LOGICAL-c411t-9eb505d93198be1fe106026eb9cae8213290b1fc90a4badeb7d772df33f436703</originalsourceid><addsrcrecordid>eNpVkctuFDEQRS0EIsPAjjXykkUcyna_vEHKY0IGhYdgMrCz3O5qxqjHbtruKOR_8p_0JCGCVUlVR7du1SXkJYcDzkX15v16eQAAZcYEPCIzDqpiec6zx2QGIATLZfV9jzyL8ScAz7Iie0r2pBAqV1DNyM0JXmIX-i36RENLDZUfxsQOe7xiX5OpXeeusaELf0shXQ1uiwNdbUyii6ve-CbSs-WacfoRxzSYCTfJBU-PBjRN2tBvG_T0Ik4aq0CPQoiJno5xR3zGPrkG2Ykb0KYJWBtrnUe26Jx1u8YXjH3wEeNz8qQ1XcQX93VOLk4Xq-Mzdv7p3fL48JzZjPPEFNY55I2SXFU18hY5FCAKrJU1WAkuhYKat1aByWrTYF02ZSmaVso2k0UJck7e3un2Y73Fxk5PmU7S_XS0GX7rYJz-f-LdRv8Il7qUUPKimARe3wsM4deIMemtixa7zngMY9RCKiiyEiYvc7J_h9ohxDhg-7CGg94lq6dk9W2yWuysvfrX2gP8N0r5Bw4aoYc</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2390647021</pqid></control><display><type>article</type><title>Development of a 3Mut-Apex-Stabilized Envelope Trimer That Expands HIV-1 Neutralization Breadth When Used To Boost Fusion Peptide-Directed Vaccine-Elicited Responses</title><source>Open Access: PubMed Central</source><source>American Society for Microbiology Journals</source><creator>Chuang, Gwo-Yu ; Lai, Yen-Ting ; Boyington, Jeffrey C ; Cheng, Cheng ; Geng, Hui ; Narpala, Sandeep ; Rawi, Reda ; Schmidt, Stephen D ; Tsybovsky, Yaroslav ; Verardi, Raffaello ; Xu, Kai ; Yang, Yongping ; Zhang, Baoshan ; Chambers, Michael ; Changela, Anita ; Corrigan, Angela R ; Kong, Rui ; Olia, Adam S ; Ou, Li ; Sarfo, Edward K ; Wang, Shuishu ; Wu, Winston ; Doria-Rose, Nicole A ; McDermott, Adrian B ; Mascola, John R ; Kwong, Peter D</creator><contributor>Silvestri, Guido</contributor><creatorcontrib>Chuang, Gwo-Yu ; Lai, Yen-Ting ; Boyington, Jeffrey C ; Cheng, Cheng ; Geng, Hui ; Narpala, Sandeep ; Rawi, Reda ; Schmidt, Stephen D ; Tsybovsky, Yaroslav ; Verardi, Raffaello ; Xu, Kai ; Yang, Yongping ; Zhang, Baoshan ; Chambers, Michael ; Changela, Anita ; Corrigan, Angela R ; Kong, Rui ; Olia, Adam S ; Ou, Li ; Sarfo, Edward K ; Wang, Shuishu ; Wu, Winston ; Doria-Rose, Nicole A ; McDermott, Adrian B ; Mascola, John R ; Kwong, Peter D ; Silvestri, Guido</creatorcontrib><description>HIV-1 envelope (Env) trimers, stabilized in a prefusion-closed conformation, can elicit humoral responses capable of neutralizing HIV-1 strains closely matched in sequence to the immunizing strain. One strategy to increase elicited neutralization breadth involves vaccine priming of immune responses against a target site of vulnerability, followed by vaccine boosting of these responses with prefusion-closed Env trimers. This strategy has succeeded at the fusion peptide (FP) site of vulnerability in eliciting cross-clade neutralizing responses in standard vaccine-test animals. However, the breadth and potency of the elicited responses have been less than optimal. Here, we identify three mutations (3mut), Met302, Leu320, and Pro329, that stabilize the apex of the Env trimer in a prefusion-closed conformation and show antigenically, structurally, and immunogenically that combining 3mut with other approaches (e.g., repair and stabilize and glycine-helix breaking) yields well-behaved clade C-Env trimers capable of boosting the breadth of FP-directed responses. Crystal structures of these trimers confirmed prefusion-closed apexes stabilized by hydrophobic patches contributed by Met302 and Leu320, with Pro329 assuming canonically restricted dihedral angles. We substituted the N-terminal eight residues of FP (FP8, residues 512 to 519) of these trimers with the second most prevalent FP8 sequence (FP8v2, AVGLGAVF) and observed a 3mut-stabilized consensus clade C-Env trimer with FP8v2 to boost the breadth elicited in guinea pigs of FP-directed responses induced by immunogens containing the most prevalent FP8 sequence (FP8v1, AVGIGAVF). Overall, 3mut can stabilize the Env trimer apex, and the resultant apex-stabilized Env trimers can be used to expand the neutralization breadth elicited against the FP site of vulnerability. A major hurdle to the development of an effective HIV-1 vaccine is the elicitation of serum responses capable of neutralizing circulating strains of HIV, which are extraordinarily diverse in sequence and often highly neutralization resistant. Recently, we showed how sera with 20 to 30% neutralization breadth could, nevertheless, be elicited in standard vaccine test animals by priming with the most prevalent N-terminal 8 residues of the HIV-1 fusion peptide (FP8), followed by boosting with a stabilized BG505-envelope (Env) trimer. Here, we show that subsequent boosting with a 3mut-apex-stabilized consensus C-Env trimer, modified to have the second most prevalent FP8 sequence, elicits higher neutralization breadth than that induced by continued boosting with the stabilized BG505-Env trimer. With increased neutralizing breadth elicited by boosting with a heterologous trimer containing the second most prevalent FP8 sequence, the fusion peptide-directed immune-focusing approach moves a step closer toward realizing an effective HIV-1 vaccine regimen.</description><identifier>ISSN: 0022-538X</identifier><identifier>ISSN: 1098-5514</identifier><identifier>EISSN: 1098-5514</identifier><identifier>DOI: 10.1128/JVI.00074-20</identifier><identifier>PMID: 32295908</identifier><language>eng</language><publisher>United States: American Society for Microbiology</publisher><subject>AIDS Vaccines - immunology ; Animals ; Antibodies, Neutralizing - immunology ; env Gene Products, Human Immunodeficiency Virus - genetics ; env Gene Products, Human Immunodeficiency Virus - immunology ; Female ; Guinea Pigs ; HEK293 Cells ; HIV Antibodies - immunology ; HIV Seropositivity ; HIV-1 - immunology ; Humans ; Immunization, Secondary ; Peptides ; Vaccines and Antiviral Agents ; Vaccines, Subunit</subject><ispartof>Journal of virology, 2020-06, Vol.94 (13)</ispartof><rights>Copyright © 2020 American Society for Microbiology.</rights><rights>Copyright © 2020 American Society for Microbiology. 2020 American Society for Microbiology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c411t-9eb505d93198be1fe106026eb9cae8213290b1fc90a4badeb7d772df33f436703</citedby><cites>FETCH-LOGICAL-c411t-9eb505d93198be1fe106026eb9cae8213290b1fc90a4badeb7d772df33f436703</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7307166/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7307166/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,3174,27903,27904,53769,53771</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32295908$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Silvestri, Guido</contributor><creatorcontrib>Chuang, Gwo-Yu</creatorcontrib><creatorcontrib>Lai, Yen-Ting</creatorcontrib><creatorcontrib>Boyington, Jeffrey C</creatorcontrib><creatorcontrib>Cheng, Cheng</creatorcontrib><creatorcontrib>Geng, Hui</creatorcontrib><creatorcontrib>Narpala, Sandeep</creatorcontrib><creatorcontrib>Rawi, Reda</creatorcontrib><creatorcontrib>Schmidt, Stephen D</creatorcontrib><creatorcontrib>Tsybovsky, Yaroslav</creatorcontrib><creatorcontrib>Verardi, Raffaello</creatorcontrib><creatorcontrib>Xu, Kai</creatorcontrib><creatorcontrib>Yang, Yongping</creatorcontrib><creatorcontrib>Zhang, Baoshan</creatorcontrib><creatorcontrib>Chambers, Michael</creatorcontrib><creatorcontrib>Changela, Anita</creatorcontrib><creatorcontrib>Corrigan, Angela R</creatorcontrib><creatorcontrib>Kong, Rui</creatorcontrib><creatorcontrib>Olia, Adam S</creatorcontrib><creatorcontrib>Ou, Li</creatorcontrib><creatorcontrib>Sarfo, Edward K</creatorcontrib><creatorcontrib>Wang, Shuishu</creatorcontrib><creatorcontrib>Wu, Winston</creatorcontrib><creatorcontrib>Doria-Rose, Nicole A</creatorcontrib><creatorcontrib>McDermott, Adrian B</creatorcontrib><creatorcontrib>Mascola, John R</creatorcontrib><creatorcontrib>Kwong, Peter D</creatorcontrib><title>Development of a 3Mut-Apex-Stabilized Envelope Trimer That Expands HIV-1 Neutralization Breadth When Used To Boost Fusion Peptide-Directed Vaccine-Elicited Responses</title><title>Journal of virology</title><addtitle>J Virol</addtitle><description>HIV-1 envelope (Env) trimers, stabilized in a prefusion-closed conformation, can elicit humoral responses capable of neutralizing HIV-1 strains closely matched in sequence to the immunizing strain. One strategy to increase elicited neutralization breadth involves vaccine priming of immune responses against a target site of vulnerability, followed by vaccine boosting of these responses with prefusion-closed Env trimers. This strategy has succeeded at the fusion peptide (FP) site of vulnerability in eliciting cross-clade neutralizing responses in standard vaccine-test animals. However, the breadth and potency of the elicited responses have been less than optimal. Here, we identify three mutations (3mut), Met302, Leu320, and Pro329, that stabilize the apex of the Env trimer in a prefusion-closed conformation and show antigenically, structurally, and immunogenically that combining 3mut with other approaches (e.g., repair and stabilize and glycine-helix breaking) yields well-behaved clade C-Env trimers capable of boosting the breadth of FP-directed responses. Crystal structures of these trimers confirmed prefusion-closed apexes stabilized by hydrophobic patches contributed by Met302 and Leu320, with Pro329 assuming canonically restricted dihedral angles. We substituted the N-terminal eight residues of FP (FP8, residues 512 to 519) of these trimers with the second most prevalent FP8 sequence (FP8v2, AVGLGAVF) and observed a 3mut-stabilized consensus clade C-Env trimer with FP8v2 to boost the breadth elicited in guinea pigs of FP-directed responses induced by immunogens containing the most prevalent FP8 sequence (FP8v1, AVGIGAVF). Overall, 3mut can stabilize the Env trimer apex, and the resultant apex-stabilized Env trimers can be used to expand the neutralization breadth elicited against the FP site of vulnerability. A major hurdle to the development of an effective HIV-1 vaccine is the elicitation of serum responses capable of neutralizing circulating strains of HIV, which are extraordinarily diverse in sequence and often highly neutralization resistant. Recently, we showed how sera with 20 to 30% neutralization breadth could, nevertheless, be elicited in standard vaccine test animals by priming with the most prevalent N-terminal 8 residues of the HIV-1 fusion peptide (FP8), followed by boosting with a stabilized BG505-envelope (Env) trimer. Here, we show that subsequent boosting with a 3mut-apex-stabilized consensus C-Env trimer, modified to have the second most prevalent FP8 sequence, elicits higher neutralization breadth than that induced by continued boosting with the stabilized BG505-Env trimer. With increased neutralizing breadth elicited by boosting with a heterologous trimer containing the second most prevalent FP8 sequence, the fusion peptide-directed immune-focusing approach moves a step closer toward realizing an effective HIV-1 vaccine regimen.</description><subject>AIDS Vaccines - immunology</subject><subject>Animals</subject><subject>Antibodies, Neutralizing - immunology</subject><subject>env Gene Products, Human Immunodeficiency Virus - genetics</subject><subject>env Gene Products, Human Immunodeficiency Virus - immunology</subject><subject>Female</subject><subject>Guinea Pigs</subject><subject>HEK293 Cells</subject><subject>HIV Antibodies - immunology</subject><subject>HIV Seropositivity</subject><subject>HIV-1 - immunology</subject><subject>Humans</subject><subject>Immunization, Secondary</subject><subject>Peptides</subject><subject>Vaccines and Antiviral Agents</subject><subject>Vaccines, Subunit</subject><issn>0022-538X</issn><issn>1098-5514</issn><issn>1098-5514</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNpVkctuFDEQRS0EIsPAjjXykkUcyna_vEHKY0IGhYdgMrCz3O5qxqjHbtruKOR_8p_0JCGCVUlVR7du1SXkJYcDzkX15v16eQAAZcYEPCIzDqpiec6zx2QGIATLZfV9jzyL8ScAz7Iie0r2pBAqV1DNyM0JXmIX-i36RENLDZUfxsQOe7xiX5OpXeeusaELf0shXQ1uiwNdbUyii6ve-CbSs-WacfoRxzSYCTfJBU-PBjRN2tBvG_T0Ik4aq0CPQoiJno5xR3zGPrkG2Ykb0KYJWBtrnUe26Jx1u8YXjH3wEeNz8qQ1XcQX93VOLk4Xq-Mzdv7p3fL48JzZjPPEFNY55I2SXFU18hY5FCAKrJU1WAkuhYKat1aByWrTYF02ZSmaVso2k0UJck7e3un2Y73Fxk5PmU7S_XS0GX7rYJz-f-LdRv8Il7qUUPKimARe3wsM4deIMemtixa7zngMY9RCKiiyEiYvc7J_h9ohxDhg-7CGg94lq6dk9W2yWuysvfrX2gP8N0r5Bw4aoYc</recordid><startdate>20200616</startdate><enddate>20200616</enddate><creator>Chuang, Gwo-Yu</creator><creator>Lai, Yen-Ting</creator><creator>Boyington, Jeffrey C</creator><creator>Cheng, Cheng</creator><creator>Geng, Hui</creator><creator>Narpala, Sandeep</creator><creator>Rawi, Reda</creator><creator>Schmidt, Stephen D</creator><creator>Tsybovsky, Yaroslav</creator><creator>Verardi, Raffaello</creator><creator>Xu, Kai</creator><creator>Yang, Yongping</creator><creator>Zhang, Baoshan</creator><creator>Chambers, Michael</creator><creator>Changela, Anita</creator><creator>Corrigan, Angela R</creator><creator>Kong, Rui</creator><creator>Olia, Adam S</creator><creator>Ou, Li</creator><creator>Sarfo, Edward K</creator><creator>Wang, Shuishu</creator><creator>Wu, Winston</creator><creator>Doria-Rose, Nicole A</creator><creator>McDermott, Adrian B</creator><creator>Mascola, John R</creator><creator>Kwong, Peter D</creator><general>American Society for Microbiology</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20200616</creationdate><title>Development of a 3Mut-Apex-Stabilized Envelope Trimer That Expands HIV-1 Neutralization Breadth When Used To Boost Fusion Peptide-Directed Vaccine-Elicited Responses</title><author>Chuang, Gwo-Yu ; Lai, Yen-Ting ; Boyington, Jeffrey C ; Cheng, Cheng ; Geng, Hui ; Narpala, Sandeep ; Rawi, Reda ; Schmidt, Stephen D ; Tsybovsky, Yaroslav ; Verardi, Raffaello ; Xu, Kai ; Yang, Yongping ; Zhang, Baoshan ; Chambers, Michael ; Changela, Anita ; Corrigan, Angela R ; Kong, Rui ; Olia, Adam S ; Ou, Li ; Sarfo, Edward K ; Wang, Shuishu ; Wu, Winston ; Doria-Rose, Nicole A ; McDermott, Adrian B ; Mascola, John R ; Kwong, Peter D</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c411t-9eb505d93198be1fe106026eb9cae8213290b1fc90a4badeb7d772df33f436703</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>AIDS Vaccines - immunology</topic><topic>Animals</topic><topic>Antibodies, Neutralizing - immunology</topic><topic>env Gene Products, Human Immunodeficiency Virus - genetics</topic><topic>env Gene Products, Human Immunodeficiency Virus - immunology</topic><topic>Female</topic><topic>Guinea Pigs</topic><topic>HEK293 Cells</topic><topic>HIV Antibodies - immunology</topic><topic>HIV Seropositivity</topic><topic>HIV-1 - immunology</topic><topic>Humans</topic><topic>Immunization, Secondary</topic><topic>Peptides</topic><topic>Vaccines and Antiviral Agents</topic><topic>Vaccines, Subunit</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chuang, Gwo-Yu</creatorcontrib><creatorcontrib>Lai, Yen-Ting</creatorcontrib><creatorcontrib>Boyington, Jeffrey C</creatorcontrib><creatorcontrib>Cheng, Cheng</creatorcontrib><creatorcontrib>Geng, Hui</creatorcontrib><creatorcontrib>Narpala, Sandeep</creatorcontrib><creatorcontrib>Rawi, Reda</creatorcontrib><creatorcontrib>Schmidt, Stephen D</creatorcontrib><creatorcontrib>Tsybovsky, Yaroslav</creatorcontrib><creatorcontrib>Verardi, Raffaello</creatorcontrib><creatorcontrib>Xu, Kai</creatorcontrib><creatorcontrib>Yang, Yongping</creatorcontrib><creatorcontrib>Zhang, Baoshan</creatorcontrib><creatorcontrib>Chambers, Michael</creatorcontrib><creatorcontrib>Changela, Anita</creatorcontrib><creatorcontrib>Corrigan, Angela R</creatorcontrib><creatorcontrib>Kong, Rui</creatorcontrib><creatorcontrib>Olia, Adam S</creatorcontrib><creatorcontrib>Ou, Li</creatorcontrib><creatorcontrib>Sarfo, Edward K</creatorcontrib><creatorcontrib>Wang, Shuishu</creatorcontrib><creatorcontrib>Wu, Winston</creatorcontrib><creatorcontrib>Doria-Rose, Nicole A</creatorcontrib><creatorcontrib>McDermott, Adrian B</creatorcontrib><creatorcontrib>Mascola, John R</creatorcontrib><creatorcontrib>Kwong, Peter D</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of virology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chuang, Gwo-Yu</au><au>Lai, Yen-Ting</au><au>Boyington, Jeffrey C</au><au>Cheng, Cheng</au><au>Geng, Hui</au><au>Narpala, Sandeep</au><au>Rawi, Reda</au><au>Schmidt, Stephen D</au><au>Tsybovsky, Yaroslav</au><au>Verardi, Raffaello</au><au>Xu, Kai</au><au>Yang, Yongping</au><au>Zhang, Baoshan</au><au>Chambers, Michael</au><au>Changela, Anita</au><au>Corrigan, Angela R</au><au>Kong, Rui</au><au>Olia, Adam S</au><au>Ou, Li</au><au>Sarfo, Edward K</au><au>Wang, Shuishu</au><au>Wu, Winston</au><au>Doria-Rose, Nicole A</au><au>McDermott, Adrian B</au><au>Mascola, John R</au><au>Kwong, Peter D</au><au>Silvestri, Guido</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Development of a 3Mut-Apex-Stabilized Envelope Trimer That Expands HIV-1 Neutralization Breadth When Used To Boost Fusion Peptide-Directed Vaccine-Elicited Responses</atitle><jtitle>Journal of virology</jtitle><addtitle>J Virol</addtitle><date>2020-06-16</date><risdate>2020</risdate><volume>94</volume><issue>13</issue><issn>0022-538X</issn><issn>1098-5514</issn><eissn>1098-5514</eissn><abstract>HIV-1 envelope (Env) trimers, stabilized in a prefusion-closed conformation, can elicit humoral responses capable of neutralizing HIV-1 strains closely matched in sequence to the immunizing strain. One strategy to increase elicited neutralization breadth involves vaccine priming of immune responses against a target site of vulnerability, followed by vaccine boosting of these responses with prefusion-closed Env trimers. This strategy has succeeded at the fusion peptide (FP) site of vulnerability in eliciting cross-clade neutralizing responses in standard vaccine-test animals. However, the breadth and potency of the elicited responses have been less than optimal. Here, we identify three mutations (3mut), Met302, Leu320, and Pro329, that stabilize the apex of the Env trimer in a prefusion-closed conformation and show antigenically, structurally, and immunogenically that combining 3mut with other approaches (e.g., repair and stabilize and glycine-helix breaking) yields well-behaved clade C-Env trimers capable of boosting the breadth of FP-directed responses. Crystal structures of these trimers confirmed prefusion-closed apexes stabilized by hydrophobic patches contributed by Met302 and Leu320, with Pro329 assuming canonically restricted dihedral angles. We substituted the N-terminal eight residues of FP (FP8, residues 512 to 519) of these trimers with the second most prevalent FP8 sequence (FP8v2, AVGLGAVF) and observed a 3mut-stabilized consensus clade C-Env trimer with FP8v2 to boost the breadth elicited in guinea pigs of FP-directed responses induced by immunogens containing the most prevalent FP8 sequence (FP8v1, AVGIGAVF). Overall, 3mut can stabilize the Env trimer apex, and the resultant apex-stabilized Env trimers can be used to expand the neutralization breadth elicited against the FP site of vulnerability. A major hurdle to the development of an effective HIV-1 vaccine is the elicitation of serum responses capable of neutralizing circulating strains of HIV, which are extraordinarily diverse in sequence and often highly neutralization resistant. Recently, we showed how sera with 20 to 30% neutralization breadth could, nevertheless, be elicited in standard vaccine test animals by priming with the most prevalent N-terminal 8 residues of the HIV-1 fusion peptide (FP8), followed by boosting with a stabilized BG505-envelope (Env) trimer. Here, we show that subsequent boosting with a 3mut-apex-stabilized consensus C-Env trimer, modified to have the second most prevalent FP8 sequence, elicits higher neutralization breadth than that induced by continued boosting with the stabilized BG505-Env trimer. With increased neutralizing breadth elicited by boosting with a heterologous trimer containing the second most prevalent FP8 sequence, the fusion peptide-directed immune-focusing approach moves a step closer toward realizing an effective HIV-1 vaccine regimen.</abstract><cop>United States</cop><pub>American Society for Microbiology</pub><pmid>32295908</pmid><doi>10.1128/JVI.00074-20</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0022-538X
ispartof Journal of virology, 2020-06, Vol.94 (13)
issn 0022-538X
1098-5514
1098-5514
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7307166
source Open Access: PubMed Central; American Society for Microbiology Journals
subjects AIDS Vaccines - immunology
Animals
Antibodies, Neutralizing - immunology
env Gene Products, Human Immunodeficiency Virus - genetics
env Gene Products, Human Immunodeficiency Virus - immunology
Female
Guinea Pigs
HEK293 Cells
HIV Antibodies - immunology
HIV Seropositivity
HIV-1 - immunology
Humans
Immunization, Secondary
Peptides
Vaccines and Antiviral Agents
Vaccines, Subunit
title Development of a 3Mut-Apex-Stabilized Envelope Trimer That Expands HIV-1 Neutralization Breadth When Used To Boost Fusion Peptide-Directed Vaccine-Elicited Responses
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-24T05%3A04%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Development%20of%20a%203Mut-Apex-Stabilized%20Envelope%20Trimer%20That%20Expands%20HIV-1%20Neutralization%20Breadth%20When%20Used%20To%20Boost%20Fusion%20Peptide-Directed%20Vaccine-Elicited%20Responses&rft.jtitle=Journal%20of%20virology&rft.au=Chuang,%20Gwo-Yu&rft.date=2020-06-16&rft.volume=94&rft.issue=13&rft.issn=0022-538X&rft.eissn=1098-5514&rft_id=info:doi/10.1128/JVI.00074-20&rft_dat=%3Cproquest_pubme%3E2390647021%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c411t-9eb505d93198be1fe106026eb9cae8213290b1fc90a4badeb7d772df33f436703%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2390647021&rft_id=info:pmid/32295908&rfr_iscdi=true